EN DE
STOCK COMPARISON

Merck KGaA vs Teva Pharma Industries Ltd: Fair Value & Quality

Both stocks run through our valuation models. Here is how Merck KGaA (MRK) and Teva Pharma Industries Ltd (TEVA) compare, as of Sep 24, 2026.

As of Sep 24, 2026, Fair Value Calculator sees Merck KGaA as the less overvalued of the two: Merck KGaA trades at €133 versus a fair value of €109 (-18%), while Teva Pharma Industries Ltd trades at $39.01 versus $20.75 (-47%).
Merck KGaA
MRK.XETRA · EUR · Health Care
-18%
upside to fair value
overvalued
Price€133
Fair Value€109
Quality62/100
Teva Pharma Industries Ltd
TEVA · USD · Health Care
-47%
upside to fair value
overvalued
Price$39.01
Fair Value$20.75
Quality50/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Merck KGaATeva Pharma Industries Ltd
Valuation
24.1×P/E (TTM)29.1×
3.14×P/S (TTM)2.64×
2.30×P/B5.79× · book value is mostly goodwill
12.9×EV/EBITDA11.4×
2.76×PEG0.92×
−18.2%Fair value upside−46.8%
1.7%Dividend yieldn/a
€2.20Dividend per sharen/a
Profitability
18%Operating margin19%
1.07×EBIT margin trend (5Y)n/a
9%Return on equity22%
5%Return on assets6%
Growth
-3%Revenue growth (YoY)2%
-1.7%Avg. growth/yr (3Y)5.0%
3.8%Avg. growth/yr (5Y)0.7%
+7.3%Value creation/yr+26.1%
Balance & size
15.5×Interest coverage (EBIT/interest)2.4×
0.36×Debt / equity1.90×
$66BMarket cap$46B
mixedGrowth qualityweak

Teva Pharma Industries Ltd leads: 6 to 7 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Merck KGaAof which business quality 61 · market factors 65 Teva Pharma Industries Ltdof which business quality 46 · market factors 80
ProfitabilityMargins and returns on capital today
41
41
Quality GrowthAre margins and returns improving?
40
53
CashflowEarnings quality: real cash, not paper profit
57
46
Fin. StrengthBalance sheet, leverage, solvency risk
76
12
InvestmentDisciplined investing over empire-building
80
98
Low VolatilityCalm price path (market factor)
72
61
MomentumPrice trend over the last 3–12 months (market factor)
59
82
52W MomentumDistance to the 52-week high (market factor)
65
98
Net IssuanceShare count: buybacks or dilution?
82
54

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyMerck KGaAPrice €133Teva Pharma Industries LtdPrice $39.01
DCF Models-19%below the price€107-45%below the price$21.52
Earnings-Based-60%below the price€53.25-75%below the price$9.66
Dividend Discount-69%below the price€40.71n/a
Multiples-11%close to the price€118-46%below the price$21.13
Asset-Based-67%below the price€44.06-88%below the price$4.55
Growth DCF-29%below the price€94.57-50%below the price$19.69
Economic Profit-50%below the price€66.44-74%below the price$10.26
Growth Earnings-13%close to the price€115-37%below the price$24.52
Minimum-69%below the price€40.71-88%below the price$4.55
Maximum-11%close to the price€118-37%below the price$24.52
Median-39%below the price€80.50-50%below the price$19.69
Geometric mean-45%below the price€73.75-64%below the price$13.87

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Merck KGaA: 22 of 26 models see the stock below the current price.

Teva Pharma Industries Ltd: 24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Merck KGaA
Price €133
Fair Value €109
Bear €59.91Bull €150
Teva Pharma Industries Ltd
Price $39.01
Fair Value $20.75
Bear $10.55Bull $31.88

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Merck KGaA · Health Care

Quality score62 · above median
Fair value upside-18% · above median

Teva Pharma Industries Ltd · Health Care

Quality score50 · below median
Fair value upside-47% · below median

Bottom line

As of Sep 24, 2026, Fair Value Calculator sees Merck KGaA as the less overvalued of the two: Merck KGaA trades at €133 versus a fair value of €109 (-18%), while Teva Pharma Industries Ltd trades at $39.01 versus $20.75 (-47%).

Merck KGaA has the higher quality score (62/100).

Open Merck KGaA live analysis →
Merck KGaA · Teva Pharma Industries Ltd

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Merck KGaA

Microsoft vs NvidiaApple vs MicrosoftNvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor Manufacturing

Related to Teva Pharma Industries Ltd

Alphabet Inc Class C vs Meta PlatformsCisco Systems vs NvidiaMicrosoft vs Taiwan Semiconductor ManufacturingApple vs Cisco Systems
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.